title: Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice.
authors: Darius M
authors: DM
authors: Moshfeghi
authors: Audina M
authors: AM
authors: Berrocal
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D017322:Clinical Trials, Phase II as Topic; D004059:Diffusion of Innovation; D006801:Humans; D007231:Infant, Newborn; D015337:Multicenter Studies as Topic; D009389:Neovascularization, Pathologic / Q000209:etiology* / Q000517:prevention & control*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012178:Retinopathy of Prematurity / Q000150:complications*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab